Le Lézard
Classified in: Covid-19 virus
Subjects: Photo/Multimedia, Contract/Agreement, Product/Service

Humana and Fresenius Medical Care North America Announce Expanded Collaboration to Improve Care Coordination


Leading health and well-being company Humana Inc. (NYSE: HUM) and leading renal care company Fresenius Medical Care North America (FMCNA) today announced an agreement to broaden their collaboration toward improving the health of eligible Humana Medicare Advantage and commercial members with chronic kidney disease (CKD) and end stage renal disease (ESRD) through more coordinated, holistic care.

The expanded partnership is in keeping with the goals outlined in the 21st Century Cures Act, which enables people with ESRD to enroll in Medicare Advantage Plans, and with federal initiatives that call for earlier diagnosis and treatment of kidney disease; a reduction in the number of Americans developing ESRD; and support for patient treatment options such as home dialysis or kidney transplant as applicable.

The agreement between Humana and Fresenius Medical Care North America goes into effect Jan. 1, 2021, and encompasses the following:

"As Humana continues to prioritize innovative solutions in response to today's greatest health care challenges, we're pleased to collaborate with Fresenius Medical Care North America, an organization of broad capability with which we can execute an important initiative of this scale," said William Shrank, M.D., M.S.H.S., Humana's Chief Medical Officer. "In the evolution of renal disease care, we are confident that the best way to improve health outcomes and the patient experience is personalized coordination that meets the needs of each individual. That's especially vital in the midst of the coronavirus pandemic."

"This agreement represents an evolution of our work with Humana and leverages our over 10 years of industry leadership in value-based care," said Bill Valle, Fresenius Medical Care North America's Chief Executive Officer. "Our scale, integrated nephrology network, and standardized clinical interventions and protocols uniquely position us to predictably and consistently improve health outcomes and reduce overall costs. We welcome this opportunity to offer more coordinated, holistic care to Humana's members, with a keen focus on education, comorbidity management, early detection, and treatment options, including home dialysis. This approach also helps eliminate barriers to keep renal disease treatment uninterrupted for at-risk populations."

Individuals with CKD have kidneys that do not filter blood properly, which causes waste and fluid levels that can be dangerously high. CKD and ESRD affect a wide spectrum of the population but the degree of impact is not uniform. For example, kidney failure rates among Black Americans are about three times that of white Americans. In total, approximately 15% of American adults, or about 37 million people, have CKD, but many are unaware of their condition. CKD management is complex, and failure to appropriately manage the condition may cause considerable symptoms and worsening health outcomes, including ESRD.

About Humana

Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools ? such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions ? combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company's web site at www.humana.com, including copies of:

Additional Information

Other providers are available in our network. The provider may also contract with other Plans.

About Fresenius Medical Care North America

Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world's largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com/.

Y0040_GHHKXUFEN_C


These press releases may also interest you

at 20:50
The global pharmaceutical caps and closures market size is expected to grow by USD 2.43 billion during 2020-2024, progressing at a CAGR of about 10% during the forecast period. Click & get FREE sample Report in MINUTES The development of child...

at 20:48
The final 2021 Medicare Physician Fee Schedule (MPFS) issued today by the Centers for Medicare & Medicaid Services (CMS) failed to provide relief from a significant shift in physician and non-physician payments expected to take effect on January 1,...

at 20:20
Robin Hood, New York's largest poverty-fighting organization, and iHeartRadio joined together to broadcast "Heroes of New York" to celebrate the true impact of the extraordinary generosity and selflessness of New Yorkers, featuring innovative and...

at 19:45
Ufovax, LLC, (Ufovax), a vaccine biotechnology company based on the Single-component Self-Assembling protein NanoParticle (1c-SApNP) vaccine design and manufacturing platform invented by Associate Professor Jiang Zhu, PhD, of Scripps Research (La...

at 19:35
The College of American Pathologists (CAP) President Patrick Godbey, MD, FCAP issued the following statement following the release of the final 2021 Medicare Physician Fee Schedule on December 1: "The CAP strongly objects to the 9% Medicare cuts to...

at 19:29
All Amounts in US Dollars Unless Otherwise Stated Fiscal 2020 Highlights: 64 K Au Oz Eq produced (53 K Au Oz & 5.6 M Cu lb) AISC at $1,582 $102 M Revenue $9.5 M EBITDA $8.7 M CAPEX $15.6 M EOY CashFiscal 2021 Guidance Highlights: Gold: 50 K ? 55 K Au...



News published on 6 october 2020 at 08:05 and distributed by: